Pages that link to "Q47667926"
Jump to navigation
Jump to search
The following pages link to Morbidity of pertussis in adolescents and adults (Q47667926):
Displaying 50 items.
- Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies (Q24522458) (← links)
- Health-state valuations for pertussis: methods for valuing short-term health states (Q24805972) (← links)
- Preventing the Spread of Pertussis in Pediatric Healthcare Settings (Q26781057) (← links)
- Novel therapies for the treatment of pertussis disease (Q28084039) (← links)
- Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis (Q28543915) (← links)
- Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model (Q28748851) (← links)
- Pertussis: Microbiology, Disease, Treatment, and Prevention (Q30251684) (← links)
- Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases (Q30401036) (← links)
- Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection (Q30416562) (← links)
- Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients (Q30599465) (← links)
- Children with pertussis inform the investigation of other pertussis cases among contacts (Q30831791) (← links)
- Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. (Q33156368) (← links)
- Serum immunoglobulin G analysis to establish a delayed diagnosis of chronic cough due to Bordetella pertussis (Q33160552) (← links)
- The epidemiology of pertussis in Germany: past and present (Q33412583) (← links)
- Pertussis immunization for adolescents: What are we waiting for? (Q33582687) (← links)
- Diagnosis and management of pertussis. (Q33833442) (← links)
- Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years (Q33974293) (← links)
- Pertussis in Florida, 2000–2006: Trends in a Historically Low-Incidence State (Q34077277) (← links)
- Rationale for pertussis booster vaccination throughout life in Europe. (Q34186477) (← links)
- Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration (Q34460351) (← links)
- Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma (Q34499739) (← links)
- The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study (Q34560049) (← links)
- Assessment of vaccine candidates for persons aged 50 and older: a review (Q34668826) (← links)
- Diagnosis of pertussis using nasopharyngeal IgA and polymerase chain reaction in specimens from outpatients in Australia (Q34743041) (← links)
- Pertussis of adults and infants (Q35017747) (← links)
- Recommendation for the use of newly introduced Tdap vaccine in Korea (Q35079298) (← links)
- Modelling the return on investment of preventively vaccinating healthcare workers against pertussis (Q35121999) (← links)
- Toxicity and potency evaluation of pertussis vaccines (Q35648263) (← links)
- NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors (Q35661304) (← links)
- A comparison of 2 strategies to prevent infection following pertussis exposure in vaccinated healthcare personnel (Q35815296) (← links)
- A Ten-Year Case-Control Study of Passive Smoke Exposure as a Risk Factor for Pertussis in Children (Q35846492) (← links)
- Increased risk of pertussis in patients with asthma (Q35875902) (← links)
- Influence of asthma epidemiology on the risk for other diseases (Q35895182) (← links)
- Pertussis vaccination for adolescents and adults (Q35907047) (← links)
- Management of acute bronchitis in healthy adults (Q35957934) (← links)
- Immunizations in the United States: a rite of passage (Q36144996) (← links)
- The role of the acellular pertussis vaccine and the demise of 'Pertussis Pete'. (Q36170267) (← links)
- Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know. (Q36256236) (← links)
- Recent developments in pertussis (Q36502509) (← links)
- Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations (Q36521834) (← links)
- Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use. (Q36623553) (← links)
- Diagnosis of pertussis: a historical review and recent developments (Q36670939) (← links)
- Pertussis resurgence: diagnosis, treatment, prevention, and beyond (Q36693838) (← links)
- Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand (Q36779361) (← links)
- Pertussis vaccination for health care workers (Q36803878) (← links)
- Two nosocomial pertussis outbreaks and their associated costs - King County, Washington, 2004. (Q36804124) (← links)
- Vaccination in the elderly: an immunological perspective (Q37084886) (← links)
- Vaccines in pregnancy: The dual benefit for pregnant women and infants (Q37130801) (← links)
- Pertussis: not only a disease of childhood (Q37188105) (← links)
- Epidemiology of pertussis in Denmark, 1995 to 2013 (Q37308086) (← links)